MedPath
NMPA Product

Granula Sulfadiazini Compositae

Product approved by National Medical Products Administration (CN)

Basic Information

Granula Sulfadiazini Compositae

复方磺胺嘧啶颗粒

磺胺嘧啶0.4g,甲氧苄啶50mg

颗粒剂

Regulatory Information

国药准字H13023621

Approved

化学药品

June 14, 2020

Company Information

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath